Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Agnosia 4Pain, Postoperative 2Pain 2Colorectal Neoplasms 2Colonic Neoplasms 2Urinary Bladder Neoplasms 1Pancreatic Neoplasms 1Osteosarcoma 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm, Residual 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Intraoperative Complications 1Inflammatory Bowel Diseases 1Diverticulitis 1Carcinoma, Renal Cell 1

Interventions

Gemcitabine 157Cisplatin 116pembrolizumab 80Nivolumab 42Carboplatin 42Paclitaxel 41Mitomycin 41Cystectomy 40Docetaxel 38atezolizumab 33Magnetic Resonance Spectroscopy 31durvalumab 30Radiotherapy 29BCG Vaccine 26avelumab 24Specimen Handling 24Doxorubicin 23enfortumab vedotin 22Fluorouracil 20Cystoscopy 20Methotrexate 17Vinblastine 16Standard of Care 15Filgrastim 14Transurethral Resection of Bladder 13Sunitinib 13Ipilimumab 13vinflunine 125-aminolevulinic acid hexyl ester 12tremelimumab 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Urinary Bladder Neoplasms × Analgesia, Epidural × Clear all
NCT04358718 2021-08-09

Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy

RenJi Hospital

Phase NA Completed
44 enrolled
Genitourinary

Urinary Bladder Neoplasms, Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡